Cyclosporine for the treatment of chronic spontaneous urticaria refractory to antihistamines and omalizumab: a case series

Int J Dermatol. 2025 Jan;64(1):219-220. doi: 10.1111/ijd.17358. Epub 2024 Jun 28.

Authors

Laura Mateu-Arrom¹, Ana M Giménez-Arnau², Vicente Expósito-Serrano³, Montserrat Bonfill-Ortí⁴, Esther Serra-Baldrich¹, Oriol Yélamos¹, Jorge Spertino¹

Affiliations

¹ Dermatology Department, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Universitat Autònoma de Barcelona, Barcelona, Spain.
² Dermatology Department, Hospital del Mar Research Institute, Universitat Pompeu Fabra, Barcelona, Spain.
³ Dermatology Department, Hospital Universitari Parc Taulí, Barcelona, Spain.
⁴ Dermatology Department, Hospital Universitari de Bellvitge, Barcelona, Spain.

PMID: 38940007
DOI: 10.1111/ijd.17358

No abstract available

Keywords: antihistamine; cyclosporine; omalizumab; response; urticaria.

Publication types

Letter